相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
Rikke Viggers et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
Dolores Shoback et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
Pauline M. Camacho et al.
Endocrine Practice (2020)
Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial
Maryam Karimi Fard et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Diagnosis and management of bone fragility in diabetes: an emerging challenge
S. L. Ferrari et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review
Panagiotis Anagnostis et al.
ENDOCRINE (2018)
Efficacy of Osteoporosis Therapies in Diabetic Patients
Ann V. Schwartz
CALCIFIED TISSUE INTERNATIONAL (2017)
Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis
Katrine Hygum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management
Stavroula A. Paschou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study
Dyah Purnamasari et al.
BMC ENDOCRINE DISORDERS (2017)
Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study
J. I. -H. Chiang et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS)
S. Di Gregorio et al.
BONE (2015)
Antidiabetic Medications and Polypharmacy
Emily P. Peron et al.
CLINICS IN GERIATRIC MEDICINE (2015)
Trabecular Bone Score as an Indicator for Skeletal Deterioration in Diabetes
Jung Hee Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Reproducibility of trabecular bone score with different scan modes using dual-energy X-ray absorptiometry: a phantom study
Michele Bandirali et al.
SKELETAL RADIOLOGY (2015)
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
Anjali P. Kusumbe et al.
NATURE (2014)
Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
C. Senn et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON-PFT, and FREEDOM trials
Ann V. Schwartz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk
William D. Leslie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus
Ji-Hyun Kim et al.
CLINICAL ENDOCRINOLOGY (2012)
Bone, sweet bone-osteoporotic fractures in diabetes mellitus
Christine Hamann et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
P. D. Miller et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
Danielle A. Eekman et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Young Ho Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2011)
Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels
Bu B. Yeap et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems?
B. Fan et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study
S. T. Harris et al.
BONE (2009)
Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men
Jenny M. Kindblom et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Once-Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women with Postmenopausal Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Relationship of Serum Osteocalcin Concentration to Insulin Secretion, Sensitivity, and Disposal with Hypocaloric Diet and Resistance Training
Jose Manuel Fernandez-Real et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy
Chih-Tai Leu et al.
BONE (2006)
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
II de Liefde et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
PD Miller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis
C Cooper et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Diabetes mellitus: Does it affect bone?
AV Schwartz
CALCIFIED TISSUE INTERNATIONAL (2003)
Diabetes and risk of fracture - The Blue Mountains Eye Study
RQ Ivers et al.
DIABETES CARE (2001)
分享论文
